Nilotinib can override dasatinib resistance in chronic myeloid leukemia patients with secondary resistance to imatinib first-line therapy.
Article Details
- CitationCopy to clipboard
Breccia M, Cannella L, Nanni M, Stefanizzi C, Alimena G
Nilotinib can override dasatinib resistance in chronic myeloid leukemia patients with secondary resistance to imatinib first-line therapy.
Acta Haematol. 2007;118(3):162-4. Epub 2007 Sep 20.
- PubMed ID
- 17890849 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs